Phosphorylated Proteomics Quantitative Method
The quantitative methods of phosphoproteomics involve a series of experimental strategies utilizing mass spectrometry to quantitatively analyze the sites, abundance, and dynamic changes of protein phosphorylation modifications in samples. This is done to understand the changes in protein phosphorylation status under different biological conditions (such as diseases, drug treatments, signal stimulation). Protein phosphorylation is one of the most common and critical reversible modifications in cell signal transduction, widely involved in signal transduction, cell cycle regulation, metabolic regulation, and disease occurrence, regulating almost all physiological processes, including metabolism, cell cycle, apoptosis, and immune response. Abnormal phosphorylation states are closely related to various diseases such as tumors, neurodegenerative diseases, and metabolic disorders. Therefore, highly sensitive and reproducible quantitative phosphoproteomics analysis has become a core technology for drug development and mechanism research. Since phosphorylated peptides typically have very low abundance within cells, are easily degraded, and biological samples have a high background protein level, it is difficult to capture these key signals without specialized strategies. Researchers need to combine enrichment techniques with different quantitative modes to accurately measure their changes. The quantitative methods of phosphoproteomics, combining phosphorylated peptide enrichment with different mass spectrometry strategies, accurately measure the abundance changes of phosphorylation sites in samples, assisting researchers in deciphering signal networks, disease mechanisms, and drug actions.
I. Principles, Advantages, and Disadvantages of Quantitative Methods in Phosphoproteomics
Common quantitative methods in phosphoproteomics can be categorized into two major types: label-free and label-based methods, each comprising different technical routes.
1、Label-free Quantification (LFQ)
(1) Principle: Comparing the abundance across different samples via peptide signal intensity (peak area) or spectral counting detected by mass spectrometry.
(2) Advantages: Simple experimental workflow, low cost, no limitation on sample quantity; easy integration with clinical cohort data.
(3) Limitations: Requires strict quality control and batch correction, data reproducibility is significantly affected by sample complexity.
2、Metabolic Labeling (SILAC, Stable Isotope Labeling by Amino acids in Cell culture)
(1) Principle: Introducing stable isotope-labeled amino acids into the cell culture medium, incorporating the label into the proteins during metabolism to achieve endogenous isotope control.
(2) Advantages: Minimal inter-sample error, suitable for studying dynamic phosphorylation regulation in cell models.
(3) Limitations: Limited to culturable cells, not applicable for clinical tissues or body fluids; long experimental cycle.
3、Chemical Labeling (TMT/iTRAQ)
(1) Principle: Chemically modifying proteolytic peptides and adding isotope tags, allowing parallel analysis of up to 18 samples.
(2) Advantages: High throughput, convenient multi-sample comparison, good sensitivity and reproducibility.
(3) Limitations: Low abundance of phosphorylated peptides, prone to ratio compression, requires optimized enrichment and MS methods (e.g., MS³).
4、Absolute Quantification (AQUA/PRM)
(1) Principle: Synthesizing isotope-labeled standard peptides as internal standards, determining the absolute concentration of target peptides using PRM or SRM.
(2) Advantages: High sensitivity, traceable, suitable for drug PK/PD research or clinical biomarker validation.
(3) Limitations: Relatively high cost, suitable for validation studies rather than large-scale screening.
II. Recommendations for Choosing Quantitative Methods in Phosphoproteomics
1、Exploratory large-scale screening: LFQ-DIA or TMT is recommended for high coverage.
2、Cell signaling pathway research: SILAC is suitable for dynamic quantification.
3、Multi-center clinical samples or drug development: PRM/AQUA can provide absolute quantification.
Quantitative phosphoproteomics is no longer a technique exclusive to a few laboratories. By reasonably selecting strategies and combining high-performance mass spectrometry platforms, researchers can rapidly decipher signal networks, discover disease biomarkers, and promote drug development. Biotree Biotech integrates multi-platform mass spectrometry and self-optimized phosphorylation enrichment and analysis processes, tailoring optimal strategies according to project needs, providing one-stop phosphoproteomics services from exploration to validation for research and corporate clients. We offer high-sensitivity, reproducible, and traceable phosphoproteomics solutions to accelerate your project from data to discovery. If you are interested in our services, please feel free to contact us.
Biotree Biotech—Characterization of Biologics, High-Quality Mass Spectrometry Services in Multi-Omics
Related Services:
How to order?






